Systemic in vivo antitumor activity of interleukin-12 against both transplantable and primary tumor

被引：14
作者：
Nishimura, T
Watanabe, K
Lee, U
Yahata, T
Ando, K
Kimura, M
Hiroyama, Y
Kobayashi, M
Herrmann, SH
Habu, S
机构：
[1] TOKAI UNIV,SCH MED,DEPT INFECT DIS,ISEHARA,KANAGAWA 25911,JAPAN
[2] TOKAI UNIV,SCH MED,DEPT MOLEC LIFE SCI,ISEHARA,KANAGAWA 25911,JAPAN
[3] DNARD INC,KAWASAKI,KANAGAWA 216,JAPAN
[4] GENET INST INC,CAMBRIDGE,MA 02140
来源：
IMMUNOLOGY LETTERS | 1995年 / 48卷 / 02期
关键词：
interleukin-12; tumor immunotherapy; primary tumor; mouse;
D O I：
10.1016/0165-2478(95)02448-4
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：149 / 152
页数：4
相关论文
共 50 条
  • [41] THE EFFECT OF INTERLEUKIN-12 IN EX-VIVO EXPANSION OF HUMAN HEMATOPOIETIC PROGENITORS
    BERTOLINI, F
    SOLIGO, D
    LAZZARI, L
    CORSINI, C
    SERVIDA, F
    SIRCHIA, G
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 90 (04) : 935 - 938
  • [42] Serum interleukin-12 and interleukin-18 levels as a tumor marker in patients with esophageal carcinoma
    Tsuboi, K
    Miyazaki, T
    Nakajima, M
    Fukai, Y
    Masuda, N
    Manda, R
    Fukuchi, M
    Kato, H
    Kuwano, H
    CANCER LETTERS, 2004, 205 (02) : 207 - 214
  • [43] Interleukin-12 gene modification exerts anti-tumor effects on murine mammary sarcoma cell line in vivo
    Li, Dan
    Yu, Hong
    Xu, Tengfei
    Li, Jinghua
    Sun, Yunfang
    Zhang, Wenqing
    CELLULAR & MOLECULAR IMMUNOLOGY, 2008, 5 (03) : 225 - 230
  • [44] Potentiatied anti-tumor effectiveness of combined therapy with interleukin-12 and mitoxantrone of L1210 leukemia in vivo
    Golab, J
    Zagozdzon, R
    Kozar, K
    Kaminski, R
    Giermasz, A
    Stoklosa, T
    Lasek, W
    Jakóbisiak, M
    ONCOLOGY REPORTS, 2000, 7 (01) : 177 - 181
  • [45] INFECTION WITH LEISHMANIA-MAJOR INDUCES INTERLEUKIN-12 PRODUCTION IN-VIVO
    VIEIRA, LQ
    HONDOWICZ, BD
    AFONSO, LCC
    WYSOCKA, M
    TRINCHIERI, G
    SCOTT, P
    IMMUNOLOGY LETTERS, 1994, 40 (02) : 157 - 161
  • [46] Interleukin-12 genetic administration suppressed metastatic liver tumor unsusceptible to CTL
    Itokawa, Y
    Mazda, O
    Ueda, Y
    Kishida, T
    Asada, H
    Cui, FD
    Fuji, N
    Fujiwara, H
    Shin-Ya, M
    Yasutomi, K
    Imanishi, J
    Yamagishi, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 314 (04) : 1072 - 1079
  • [47] Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12
    Guillermo Mazzolini
    Cheng Qian
    Xiaoming Xie
    Yonglian Sun
    Juan J Lasarte
    Marek Drozdzik
    Jesús Prieto
    Cancer Gene Therapy, 1999, 6 : 514 - 522
  • [48] Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12
    Mazzolini, G
    Qian, C
    Xie, XM
    Sun, YL
    Lasarte, JJ
    Drozdzik, M
    Prieto, J
    CANCER GENE THERAPY, 1999, 6 (06) : 514 - 522
  • [49] Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12
    Gambotto, A
    Tüting, T
    McVey, DL
    Kovesdi, I
    Tahara, H
    Lotze, MT
    Robbins, PD
    CANCER GENE THERAPY, 1999, 6 (01) : 45 - 53
  • [50] Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12
    Andrea Gambotto
    Thomas Tüting
    Duncan L McVey
    Imre Kovesdi
    Hideaki Tahara
    Michael T Lotze
    Paul D Robbins
    Cancer Gene Therapy, 1999, 6 : 45 - 53
12345